Tannin Capital’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$412K Sell
4,776
-200
-4% -$17.8K 0.31% 87
2026
Q2
$450K Sell
4,976
-582
-10% -$48.8K 0.3% 92
2026
Q1
$445K Buy
+5,558
New +$458K 0.32% 83

Other funds holding EW

Tannin Capital's EW Position: Q3 2026 in Review

Tannin Capital reduced its Edwards Lifesciences (EW) stake by 4% in Q3 2026, selling an estimated $17.8K and leaving 4,776 shares worth $412K. The position accounts for 0.31% of the portfolio, ranked #87.

Tannin Capital first reported a position in EW in Q1 2026 and has held it in 3 quarters since. The position peaked at $450K in Q2 2026. 1,344 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Tannin Capital held 4,776 shares of Edwards Lifesciences worth $412K as of Q3 2026.
  • Tannin Capital sold 200 Edwards Lifesciences shares in Q3 2026, an estimated $17.8K.
  • Edwards Lifesciences made up 0.31% of Tannin Capital's portfolio in Q3 2026, its #87 holding.
  • Tannin Capital first reported a position in Edwards Lifesciences in Q1 2026 and has held it in 3 quarters since.
  • Tannin Capital's Edwards Lifesciences position peaked at $450K in Q2 2026.
  • 1,344 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Tannin Capital's 13F filing for Q3 2026, filed 5 Nov 2026.